| NRF2-regulated cell cycle arrest at early stage of oxidative stress response mechanism M Márton, N Tihanyi, P Gyulavari, G Banhegyi, O Kapuy PloS one 13 (11), 2018 | 32 | 2018 |
| Discovery of N-[4-(Quinolin-4-yloxy)phenyl]benzenesulfonamides as Novel AXL Kinase Inhibitors I Szabadkai, R Torka, R Garamvölgyi, F Baska, P Gyulavári, S Boros, ... Journal of medicinal chemistry 61 (14), 6277-6292, 2018 | 27 | 2018 |
| Discovery and biological evaluation of novel dual EGFR/c-Met inhibitors B Szokol, P Gyulavári, I Kurkó, F Baska, C Szántai-Kis, Z Greff, Z Őrfi, ... ACS medicinal chemistry letters 5 (4), 298-303, 2014 | 17 | 2014 |
| Synthesis, characterization and systematic comparison of FITC‐labelled GnRH‐I,‐II and‐III analogues on various tumour cells J Murányi, P Gyulavári, A Varga, G Bökönyi, H Tanai, T Vántus, D Pap, ... Journal of Peptide Science 22 (8), 552-560, 2016 | 16 | 2016 |
| Targeting vascular endothelial growth factor receptor 2 and protein kinase D1 related pathways by a multiple kinase inhibitor in angiogenesis and inflammation related processes … A Varga, P Gyulavári, Z Greff, K Futosi, T Németh, L Simon-Szabó, ... PloS one 10 (4), e0124234, 2015 | 13 | 2015 |
| Novel Crizotinib–GnRH conjugates revealed the significance of lysosomal trapping in GnRH-based drug delivery systems J Murányi, A Varga, P Gyulavári, K Pénzes, CE Németh, M Csala, L Pethő, ... International Journal of Molecular Sciences 20 (22), 5590, 2019 | 9 | 2019 |
| The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers–In Vitro Studies B Gurbi, D Brauswetter, A Varga, P Gyulavári, K Pénzes, J Murányi, ... Cancers 11 (12), 1848, 2019 | 8 | 2019 |
| Combination of multifunctional ursolic acid with kinase inhibitors for anti-cancer drug carrier vesicles A Lőrincz, J Mihály, A Wacha, C Németh, B Besztercei, P Gyulavári, ... Materials Science and Engineering: C 131, 112481, 2021 | 7 | 2021 |
| Discovery and optimization of novel benzothiophene-3-carboxamides as highly potent inhibitors of Aurora kinases A and B P Gyulavári, B Szokol, I Szabadkai, D Brauswetter, P Bánhegyi, A Varga, ... Bioorganic & medicinal chemistry letters 28 (19), 3265-3270, 2018 | 5 | 2018 |
| Observations on mycorrhization of pecan seedlings with a European truffle AA Habtemariam, Z Bratek, P Gyulavári Rhizosphere 19, 100409, 2021 | 4 | 2021 |
| Development and biochemical characterization of EGFR/c-Met dual inhibitors B Szokol, P Gyulavári, F Baska, K Ibolya, Z Greff, KC Szántai, O Zoltán, ... Acta pharmaceutica Hungarica 83 (4), 121-133, 2013 | 3 | 2013 |
| Protein Kinase D3 (PKD3) Requires Hsp90 for Stability and Promotion of Prostate Cancer Cell Migration A Varga, MT Nguyen, K Pénzes, B Bátai, P Gyulavári, B Gurbi, J Murányi, ... Cells 12 (2), 212, 2023 | 2 | 2023 |
| In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues J Murányi, A Varga, B Gurbi, P Gyulavári, G Mező, T Vántus JoVE (Journal of Visualized Experiments), e55529, 2017 | 1 | 2017 |
| 2012P Heat shock protein 90 chaperones and protein kinase D3 regulates androgen-independent prostate cancer development A Varga, B Bátai, P Gyulavári, MT Nguyen, C Sőti, T Vántus Annals of Oncology 30 (Supplement_5), mdz269. 030, 2019 | | 2019 |
| Novel kinase inhibitor compounds for combination cancer therapy P Gyulavári Semmelweis University, 2019 | | 2019 |
| Correction: Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation … A Varga, P Gyulavári, Z Greff, K Futosi, T Németh, L Simon-Szabó, ... PloS one 10 (12), e0144792, 2015 | | 2015 |
| Optimization of novel benzothiophene-3-carboxamide inhibitors of Aurora kinases P Gyulavári, B Szokol, K Pénzes, I Szabadkai, Z Greff, D Brauswetter, ... The Febs Journal 282, 2015 | | 2015 |
| Characterization of a novel protein kinase D1 inhibitor using different inflammatory cell models A Varga, P Gyulavari, Z Greff, T Nemeth, D Brauswetter, M Kokas, L Orfi, ... The Febs Journal 281, 2014 | | 2014 |
| New benzothiophene-3-carboxamide based Aurora kinase inhibitors: SUN-037 P Gyulavári, B Szokol, K Pénzes, I Szabadkai, Z Greff, D Brauswetter, ... The Febs Journal 281, 2014 | | 2014 |
| In vitroand cellular study of benzothiophene-3-carboxamides as inhibitors of Aurora kinase family: SW04. S16–159 P Gyulavari, K Penzes, T Vantus, P Banhegyi, B Szokol, Z Greff, L Orfi, ... The Febs Journal 280 (1), 2013 | | 2013 |
Laszlo OrfiDepartment of Pharmaceutical Chemistry, Semmelweis University, Vichem Ltd.在 vichem.hu 的电子邮件经过验证
